These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 6773704

  • 1. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB, Glew RH, Radin NS, Vunnam RR.
    Clin Chim Acta; 1980 Sep 25; 106(2):155-63. PubMed ID: 6773704
    [Abstract] [Full Text] [Related]

  • 2. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB, Glew RH, Diven WF, Lee RE, Radin NS.
    Clin Chim Acta; 1981 Sep 25; 115(3):369-75. PubMed ID: 6794954
    [Abstract] [Full Text] [Related]

  • 3. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB, Coyle PJ, Chiao YB, Glew RH, Labow RS.
    J Biol Chem; 1981 Dec 25; 256(24):13004-13. PubMed ID: 6796580
    [Abstract] [Full Text] [Related]

  • 4. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
    Chiao YB, Glew RH, Diven WF, Lee RE.
    Clin Chim Acta; 1980 Jul 17; 105(1):41-50. PubMed ID: 6772352
    [No Abstract] [Full Text] [Related]

  • 5. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB, Coyle PJ, Glew RH, Radin NS, Labow RS.
    Arch Neurol; 1982 Sep 17; 39(9):550-6. PubMed ID: 6810854
    [Abstract] [Full Text] [Related]

  • 6. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
    Butcher BA, Gopalan V, Lee RE, Richards TC, Waggoner AS, Glew RH.
    Clin Chim Acta; 1989 Oct 16; 184(3):235-42. PubMed ID: 2515009
    [Abstract] [Full Text] [Related]

  • 7. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH, Daniels LB, Clark LS, Hoyer SW.
    J Neuropathol Exp Neurol; 1982 Nov 16; 41(6):630-41. PubMed ID: 6813430
    [Abstract] [Full Text] [Related]

  • 8. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
    Yatziv S, Newburg DS, Livni N, Barfi G, Kolodny EH.
    J Lab Clin Med; 1988 Apr 16; 111(4):416-20. PubMed ID: 3351378
    [Abstract] [Full Text] [Related]

  • 9. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A, Prence E, Garrett K, Glew RH, Ellingson JS.
    Arch Biochem Biophys; 1985 Nov 15; 243(1):28-34. PubMed ID: 3933429
    [Abstract] [Full Text] [Related]

  • 10. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y, Nadler HL.
    J Clin Pathol; 1978 Nov 15; 31(11):1091-3. PubMed ID: 105017
    [Abstract] [Full Text] [Related]

  • 11. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J, Broadhead DM.
    Clin Chim Acta; 1978 Aug 01; 87(3):433-40. PubMed ID: 28186
    [Abstract] [Full Text] [Related]

  • 12. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB, Glew RH.
    Clin Chem; 1982 Apr 01; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A, Glew RH.
    J Biol Chem; 1985 Oct 25; 260(24):13067-73. PubMed ID: 3932339
    [Abstract] [Full Text] [Related]

  • 14. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO, Prence EM, Glew RH.
    Arch Biochem Biophys; 1985 Apr 25; 238(1):344-52. PubMed ID: 3920967
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
    Basu A, Glew RH.
    Biochem J; 1984 Dec 01; 224(2):515-24. PubMed ID: 6517862
    [Abstract] [Full Text] [Related]

  • 16. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M, Sakiyama T, Kitagawa T.
    Pediatr Res; 1977 May 01; 11(5):641-6. PubMed ID: 870871
    [Abstract] [Full Text] [Related]

  • 17. [Beta-glucosidases. Molecular bases of Gaucher's disease].
    Maret A, Salvayre R, Negre A, Douste-Blazy L.
    Pathol Biol (Paris); 1985 Jun 01; 33(6):693-713. PubMed ID: 3931039
    [Abstract] [Full Text] [Related]

  • 18. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH, Gopalan V, Hubbell CA, Devraj RV, Lawson RA, Diven WF, Mannock DA.
    Biochem J; 1991 Mar 01; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [Abstract] [Full Text] [Related]

  • 19. Effectors of three beta-glucosidases from human liver.
    Daniels LB, Gnarra JR, Glew RH.
    Prog Clin Biol Res; 1982 Mar 01; 95():333-55. PubMed ID: 6812077
    [Abstract] [Full Text] [Related]

  • 20. Gaucher's disease.
    Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahasrabudhe GS, Chole PV.
    J Assoc Physicians India; 2009 May 01; 57():410-1. PubMed ID: 19634291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.